Validation of the French Version of the Primary Lateral Sclerosis Functioning Rating Scale (PLSFRS)
Launched by UNIVERSITY HOSPITAL, TOURS · Mar 10, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This is a prospective study conducted in 8 French ALS centers which will enroll 80 patients with PLS. All these patients will undergo an evaluation of their functional status from the ALSFRS-r and PLSFRS scales. All patients will be evaluated at 3 time points (T0,M6 at the outpatient clinic) and at M3 remotely. The aim of the study will be to validate a trans-cultural and psychometric version of the PLSFRS available for the French PLS population.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with primary lateral sclerosis (PLS)
- • Age over 18 years
- • Informed consent signed
- • Patients cared in a French ALS centre
- Exclusion Criteria:
- • patients with no oral and written command of the French language
- • Patients unable to answer a questionnaire
- • Opposition to data processing
Trial Officials
Philippe CORCIA, PR
Principal Investigator
University Hospital, Tours
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lille, , France
Tours, , France
Brest, , France
Clermont Ferrand, , France
Limoges, , France
Lyon, , France
Nice, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported